ATE444493T1 - Verfahren zur identifikation von salzempfindlichen personen - Google Patents
Verfahren zur identifikation von salzempfindlichen personenInfo
- Publication number
- ATE444493T1 ATE444493T1 AT03764573T AT03764573T ATE444493T1 AT E444493 T1 ATE444493 T1 AT E444493T1 AT 03764573 T AT03764573 T AT 03764573T AT 03764573 T AT03764573 T AT 03764573T AT E444493 T1 ATE444493 T1 AT E444493T1
- Authority
- AT
- Austria
- Prior art keywords
- salt
- binding activity
- sensitive persons
- sensitivity
- identifying salt
- Prior art date
Links
- 230000027455 binding Effects 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000035945 sensitivity Effects 0.000 abstract 2
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 abstract 1
- JWUBBDSIWDLEOM-DCHLRESJSA-N 25-Hydroxyvitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C/C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DCHLRESJSA-N 0.000 abstract 1
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 102000050760 Vitamin D-binding protein Human genes 0.000 abstract 1
- 108700021020 Vitamin D-binding protein Proteins 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/321—Arterial hypertension
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39545702P | 2002-07-12 | 2002-07-12 | |
| PCT/US2003/021843 WO2004006844A2 (en) | 2002-07-12 | 2003-07-11 | Method for identifying salt-sensitive persons |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE444493T1 true ATE444493T1 (de) | 2009-10-15 |
Family
ID=30115875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03764573T ATE444493T1 (de) | 2002-07-12 | 2003-07-11 | Verfahren zur identifikation von salzempfindlichen personen |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7888000B2 (de) |
| EP (1) | EP1534075B1 (de) |
| AT (1) | ATE444493T1 (de) |
| AU (1) | AU2003256515A1 (de) |
| DE (1) | DE60329500D1 (de) |
| WO (1) | WO2004006844A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2633325B1 (de) * | 2010-10-29 | 2016-12-28 | Cohesive Technologies Inc. | Lc-ms-trennung und detektion von vitamin-d-metaboliten |
| AU2011320345C1 (en) | 2010-10-29 | 2017-04-06 | Cohesive Technologies Inc. | LC-MS configuration for purification and detection of analytes having a broad range of hydrophobicities |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3772150A (en) * | 1971-12-29 | 1973-11-13 | Us Health | Process for producing vitamin d{11 {11 metabolite |
| US4269777A (en) * | 1979-05-21 | 1981-05-26 | Wisconsin Alumni Research Foundation | Isotopically labeled vitamin D derivatives and processes for preparing same |
| US4229359A (en) * | 1979-09-04 | 1980-10-21 | Wisconsin Alumni Research Foundation | Derivatives of 25-hydroxycholecalciferol |
| US4883791A (en) * | 1987-09-21 | 1989-11-28 | Board Of Regents, The University Of Texas System | 25S,26-dihydroxycholecalciferol in the treatment of hypercalcitriolemic disease states |
| US5202266A (en) | 1987-10-14 | 1993-04-13 | Asahi Kasei Kogyo Kabushiki Kaisha | 25-hydroxy vitamin D3 derivatives, process for their production, and assay method using the same |
| DE69407923T2 (de) * | 1993-05-17 | 1998-04-30 | Amersham Int Plc | Vorrichtung und verfahren zum nachweis zellularer und biochemischer prozesse |
| GB9317193D0 (en) * | 1993-08-18 | 1993-10-06 | Zeneca Ltd | Method |
| US6010861A (en) * | 1994-08-03 | 2000-01-04 | Dgi Biotechnologies, Llc | Target specific screens and their use for discovering small organic molecular pharmacophores |
| US5695794A (en) * | 1995-08-10 | 1997-12-09 | Amoco Corporation | Use of 25-hydroxycholecalciferol in a dietary supplement process for ameliorating the effects of tibial dyschondroplasia in poultry while maintaining weight gain |
| AU763458B2 (en) | 1998-06-25 | 2003-07-24 | Biomedica Gmbh | Functional vitamin D derivatives and a method for determining 25-hydroxy-vitamin D and 1alpha,25-dihydroxy-vitamin D |
| US6610504B1 (en) * | 2000-04-10 | 2003-08-26 | General Atomics | Methods of determining SAM-dependent methyltransferase activity using a mutant SAH hydrolase |
| GB0029729D0 (en) * | 2000-12-06 | 2001-01-17 | Ids Ltd | Method for detection of vitamin D metabolites |
| US7087395B1 (en) | 2001-01-16 | 2006-08-08 | Quest Diagnostics Investments Incorporated | Vitamin D assay |
-
2003
- 2003-07-11 US US10/617,254 patent/US7888000B2/en not_active Expired - Fee Related
- 2003-07-11 DE DE60329500T patent/DE60329500D1/de not_active Expired - Lifetime
- 2003-07-11 AT AT03764573T patent/ATE444493T1/de not_active IP Right Cessation
- 2003-07-11 EP EP03764573A patent/EP1534075B1/de not_active Expired - Lifetime
- 2003-07-11 AU AU2003256515A patent/AU2003256515A1/en not_active Abandoned
- 2003-07-11 WO PCT/US2003/021843 patent/WO2004006844A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003256515A1 (en) | 2004-02-02 |
| DE60329500D1 (de) | 2009-11-12 |
| US20040072374A1 (en) | 2004-04-15 |
| WO2004006844A2 (en) | 2004-01-22 |
| EP1534075A2 (de) | 2005-06-01 |
| US7888000B2 (en) | 2011-02-15 |
| AU2003256515A8 (en) | 2004-02-02 |
| WO2004006844A3 (en) | 2004-06-24 |
| EP1534075B1 (de) | 2009-09-30 |
| EP1534075A4 (de) | 2007-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60320101D1 (de) | Verfahren für regressionsanalyse von formationsparametern | |
| DE60223561D1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
| ATE460668T1 (de) | Verfahren zur prognose von brustkrebs mittels quantifizierung von zellulären folat vitamin rezeptoren | |
| DE60040677D1 (de) | Verbessertes toxizität-screening verfahren | |
| ATE514950T1 (de) | Verfahren zur untersuchung von sepsis bei menschen | |
| CY1110337T1 (el) | Παρασκευη πρεγκαμπαλινης και σχετικων ενωσεων | |
| WO2004057336A3 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
| DE60307617D1 (de) | Verfahren zur gewinnung von gold | |
| EP1643894A4 (de) | Verfahren, kits und antikörper zum nachweis von parathyroid | |
| ATE410677T1 (de) | Bioäquivalenztest für eisenhaltige formulierungen | |
| WO2005012901A3 (en) | Method for measuring aromatase activity | |
| ATE414701T1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren | |
| ATE495243T1 (de) | Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung | |
| DE60301283D1 (de) | Verfahren zur Bestimmung von Biopolymeren | |
| WO2003076896A3 (en) | Use of biomarkers to detect breast cancer | |
| ATE482398T1 (de) | Verfahren zur stratifizierung von herzinsuffizienz | |
| DE60329500D1 (de) | Verfahren zur identifikation von salzempfindlichen personen | |
| MXPA04004018A (es) | Metodos de separacion por exclusion para toxicidad de compuestos de prueba. | |
| DE602007004570D1 (de) | Verwendung von Nogo-C bei der Beurteilung von Herzversagen | |
| EP1533616A4 (de) | Detektionskitt, darin zu verwendende assay-platte, detektionsverfahren, auswertungsverfahren, polyklonalantikörper von frosch-vitellogenin und prozess zur herstellung davon | |
| DE50308468D1 (de) | Verfahren zur störbefreiung von messignalen | |
| ATE359516T1 (de) | Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs | |
| DE50312755D1 (de) | Verfahren zur Bestimmung des Verschleisses eines elektrochemischen Energiespeichers | |
| ATE447610T1 (de) | Kristalliner vap-1 und verwendung | |
| DE602006010599D1 (de) | System und verfahren zur quantitativen anwendungsmessung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |